Severe acute interstitial pnuemonia and gefitinib [3]

Lung Cancer

Volumn 43, Issue 3, 2004, Pages 367-368

  Sumpter, Kate ^a   Harper Wynne, Catherine ^a   O'Brien, Mary ^a   Congleton, Jo ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CISPLATIN; CORTICOSTEROID; GEFITINIB; GEMCITABINE;

ADULT; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CAUSE OF DEATH; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG RESPONSE; DYSPNEA; HUMAN; INTERSTITIAL PNEUMONIA; LETTER; LOBECTOMY; LUNG METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

EID: 1242328767     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2003.09.016     Document Type: Letter

References (2)

1. Inoue A., Saijo Y., Maemondo M., Gomi K., Tokue Y., Kimiua Y.et al. Severe acute interstitial pneumonia and gefitinib. Lancet. 61:2003;137-139.
2. Teramoto S., Yamamoto H., Ouchi Y. Clinical efficacy and toxicity of gefitinib in patients with lung cancer. Lancet. 361:2003;1992.